The company has already flagged a US$65 million revenue headwind in Q1 2026 tied to tighter rules around compounded semaglutide shipping, and the Novo Nordisk patent case plus FDA and SEC scrutiny add another layer of uncertainty around how much of this revenue is sustainable and at what margin
1419.556 g/mol Purity Research Use $45.00
CHAC1 catalyzes the degradation of GSH into 5-oxoproline and cysteinylglycine
most programs cap total referral earnings per calendar year
8 Its available privately on prescription, including through Second Nature, in the same way injectable Wegovy and Mounjaro first reached UK patients
Currently approved to treat type 2 diabetes and obesity, this drug class has also shown potential in other indications, from nonalcoholic fatty liver disease and cardiovascular disease to addiction, and recent studies suggest it may help tackle another big targetAlzheimers disease